Archive for the 'Diabetes Drug' Category存檔為'糖尿病藥物'類別
Type 2 Diabetics May Enjoy Insulin Free Future 2型糖尿病的胰島素，可享有免費的未來
Tuesday, June 17th, 2008 週二， 2008年6月17日Researchers from the Veterans Affairs Northern California Health Care System in Martinez, California have found out that the type 2 diabetes patients may live an insulin free life.研究人員從退伍軍人事務部北加州衛生保健制度，馬丁內斯，美國加州發現指出， 2型糖尿病病人可能活一胰島素自由的生活。 They can live a life on oral medications only.他們可以活的生活，就只有口服藥物。 But experts say more studies are needed in the subject.但專家說，進行更多的研究需要在這一主題。
Novel Combination Drug May Reverse / Cure Type 1 Diabetes (IDDM)新型的組合藥物可能扭轉/治療1型糖尿病（胰島素依賴型糖尿病）
Monday, June 16th, 2008 週一， 2008年6月16日Novo Nordisk’s Drug Liraglutide Better Than Byetta in Type 2 Diabetes (NIDDM) Control諾和諾德公司的藥物liraglutide優於byetta在2型糖尿病（非胰島素依賴型糖尿病）的控制
Wednesday, June 11th, 2008 週三， 2008年6月11日Takeda’s Once Daily Drug Alogliptin ( DPP-4 Inhibitor ) Successful in Type 2 Diabetes Control武田的每日一次的藥物alogliptin （民進黨- 4抑製劑）成功在2型糖尿病控制
Wednesday, June 11th, 2008 週三， 2008年6月11日AstraZeneca’s Oral Drug Onglyza (Saxagliptin) Successful in Type 2 Diabetes Control, May Be Available Soon阿斯利康公司的口服藥物onglyza （ saxagliptin ）成功地在2型糖尿病的控制，可能會很快提供
Wednesday, June 11th, 2008 週三， 2008年6月11日Pipex Pharmaceuticals To Acquire Exclusive Worldwid License To Use Oral Flupirtine for Diabetes, Diabetic Retinopathy, Retinities Pigmentosa & Glaucoma Treatment pipex藥品獲得獨家worldwid授權使用口服flupirtine為糖尿病，糖尿病性視網膜病變， retinities色素變性及青光眼治療
Sunday, June 8th, 2008 週日， 2008年6月8日The Pharmaceutical company Pipex Pharmaceutical has announced its plan to acquire worldwide license to the issued and pending patent applications related to additional uses of oral flupirtine for the treatment of a range of ophthalmic, diabetes and diabetes-related therapeutic indications.製藥公司pipex製藥已宣布計劃收購的全球許可，去發行和等候專利申請有關的額外用途的口腔flupirtine用於治療一系列的眼科，糖尿病和糖尿病相關的治療適應症。
Booming Kenyan Diabetes Medicine & Test Market Near $27 Million蓬勃發展的肯尼亞糖尿病醫藥與測試市場近2700萬美元
Wednesday, June 4th, 2008 週三， 2008年6月4日According to the survey conducted by the market consultancy firm Frost and Sullivan the diabetes medicines and diagnostic tests market in Kenya is likely to hit a $26.8 market in the coming year.根據所進行的調查，市場顧問公司弗羅斯特沙利文和糖尿病的藥品和診斷測試市場，在肯尼亞有可能擊中二十六點八美元市場在未來一年。 Kenya already has a diabetes market of $18 million, the third highest in the sub Saharan Africa.肯尼亞已經有一個糖尿病市場的1800萬美元，第三高，在撒哈拉以南非洲。 [...] [ … … ]
R1583 Diabetes (Type 2) Drug Gets Strong Rating r1583糖尿病（ 2型）藥物得到強有力的評級
Friday, May 30th, 2008 週五， 2008年5月30日A drug having code number R 1583, a Swiss company’s product, is going to mark a significant improvement in the history of medical Diabetes.藥物有代碼數R 1583年，一家瑞士公司的產品，是要馬克顯著改善在歷史上的醫療糖尿病。
Vaccine Reverses Type 1 Diabetes in Mice, Human Trial Begins疫苗逆轉1型糖尿病的小鼠，人體試驗開始
Friday, May 30th, 2008 週五， 2008年5月30日The researchers at the Children’s Hospital of Pittsburgh reported to have invented the experimental vaccine for the type 1 diabetes.研究人員在兒童醫院的匹茲堡據報已發明了實驗性疫苗為1型糖尿病。 The vaccine has already been tested on animal and is ready to be tested on human being.該疫苗已在動物試驗，並準備測試，對人類福祉。 Safety trial of this vaccine is going on.安全試驗這種疫苗正在進行中。 If approved, the vaccine will enter to the phase 2 [...]如獲批准，該疫苗將進入到第2期[ … … ]
